Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The immune system in atherosclerosis.

Hansson GK, Hermansson A.

Nat Immunol. 2011 Mar;12(3):204-12. doi: 10.1038/ni.2001. Review.

PMID:
21321594
2.

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.

Stoll G, Bendszus M.

Stroke. 2006 Jul;37(7):1923-32. Epub 2006 Jun 1. Review.

3.

Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.

Rao LN, Ponnusamy T, Philip S, Mukhopadhyay R, Kakkar VV, Mundkur L.

Lipids. 2015 Aug;50(8):785-97. doi: 10.1007/s11745-015-4046-4. Epub 2015 Jul 16.

PMID:
26178198
4.

Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein.

Lou Y, Liu S, Zhang C, Zhang G, Li J, Ni M, An G, Dong M, Liu X, Zhu F, Zhang W, Gao F, Chen YH, Zhang Y.

J Immunol. 2013 Nov 1;191(9):4849-57. doi: 10.4049/jimmunol.1300053. Epub 2013 Sep 30.

5.

Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.

Nilsson J, Wigren M, Shah PK.

Trends Cardiovasc Med. 2009 Nov;19(8):272-6. doi: 10.1016/j.tcm.2010.02.010. Review.

PMID:
20447570
6.

Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value.

Sobenin IA, Salonen JT, Zhelankin AV, Melnichenko AA, Kaikkonen J, Bobryshev YV, Orekhov AN.

Biomed Res Int. 2014;2014:205697. doi: 10.1155/2014/205697. Epub 2014 Jun 18. Review.

7.

Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice.

Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy G, Chapman MJ, Lesnik P.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1625-31. Epub 2007 Apr 19.

8.

Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice.

Dimayuga PC, Zhao X, Yano J, Chyu KY.

Am J Physiol Regul Integr Comp Physiol. 2006 Dec;291(6):R1644-50. Epub 2006 Jul 6.

9.

Complement and atherosclerosis-united to the point of no return?

Torzewski M, Bhakdi S.

Clin Biochem. 2013 Jan;46(1-2):20-5. doi: 10.1016/j.clinbiochem.2012.09.012. Epub 2012 Sep 23. Review.

PMID:
23010447
10.

Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.

Rahtu-Korpela L, Määttä J, Dimova EY, Hörkkö S, Gylling H, Walkinshaw G, Hakkola J, Kivirikko KI, Myllyharju J, Serpi R, Koivunen P.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):608-17. doi: 10.1161/ATVBAHA.115.307136. Epub 2016 Feb 4.

11.

The immunology of atherosclerosis.

Gisterå A, Hansson GK.

Nat Rev Nephrol. 2017 Jun;13(6):368-380. doi: 10.1038/nrneph.2017.51. Epub 2017 Apr 10. Review.

PMID:
28392564
12.

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

van Puijvelde GH, Hauer AD, de Vos P, van den Heuvel R, van Herwijnen MJ, van der Zee R, van Eden W, van Berkel TJ, Kuiper J.

Circulation. 2006 Oct 31;114(18):1968-76. Epub 2006 Oct 23.

13.

RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction.

Hu YW, Zhao JY, Li SF, Huang JL, Qiu YR, Ma X, Wu SG, Chen ZP, Hu YR, Yang JY, Wang YC, Gao JJ, Sha YH, Zheng L, Wang Q.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):87-101. doi: 10.1161/ATVBAHA.114.304296. Epub 2014 Aug 14.

14.

Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice.

Hjerpe C, Johansson D, Hermansson A, Hansson GK, Zhou X.

Atherosclerosis. 2010 Apr;209(2):436-41. doi: 10.1016/j.atherosclerosis.2009.10.003. Epub 2009 Nov 7.

PMID:
19897195
15.

AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction.

Huang Q, Qin L, Dai S, Zhang H, Pasula S, Zhou H, Chen H, Min W.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):795-804. doi: 10.1161/ATVBAHA.113.301220. Epub 2013 Feb 14.

16.

Lymphocytes in atherosclerosis.

Wigren M, Nilsson J, Kolbus D.

Clin Chim Acta. 2012 Oct 9;413(19-20):1562-8. doi: 10.1016/j.cca.2012.04.031. Epub 2012 May 4. Review.

PMID:
22565046
17.

Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.

Björkbacka H, Fredrikson GN, Nilsson J.

Atherosclerosis. 2013 Mar;227(1):9-17. doi: 10.1016/j.atherosclerosis.2012.10.074. Epub 2012 Nov 6. Review.

PMID:
23177975
18.

Adaptive Response of T and B Cells in Atherosclerosis.

Ketelhuth DF, Hansson GK.

Circ Res. 2016 Feb 19;118(4):668-78. doi: 10.1161/CIRCRESAHA.115.306427. Review.

19.

Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.

Minerva Cardioangiol. 2007 Dec;55(6):821-37. Review.

PMID:
18091649
20.

The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.

Hovland A, Jonasson L, Garred P, Yndestad A, Aukrust P, Lappegård KT, Espevik T, Mollnes TE.

Atherosclerosis. 2015 Aug;241(2):480-94. doi: 10.1016/j.atherosclerosis.2015.05.038. Epub 2015 Jun 5. Review.

Supplemental Content

Support Center